Jie Wu

Prof. Jie Wu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2016 in Journal of Arrhythmia
Verified
Journal Article
Open access
JWJie Wu
Jie Wu
WDWei-Guang Ding
Wei-Guang Ding
MHMinoru Horie
Minoru Horie
Long QT syndrome type 1 (LQT1) is a subtype of a congenital cardiac syndrome caused by mutation in the KCNQ1 gene, which encodes the α‐subunit of the slow component of delayed rectifier K+ current (IKs) channel. Arrhythmias in LQT1 are characterized by prolongation of the QT interval on ECG, as well as the occurrence of life‐threatening cardiac events, frequently triggered by adrenergic stimuli (e.g., physical or emotional stress). During the past two decades, much advancement has been made in understanding the molecular pathogenesis underlying LQT1. Uncovering the genotype‐phenotype correlations in LQT1 is of clinical importance to better understand the gene‐specific differences that may influence the propensity for developing life‐threatening arrhythmias under specific conditions. Elucidation of these mechanisms will also help to improve the diagnosis and management of this cardiac disorder based on gene‐specific considerations. This review describes the current medical consensus and recent developments regarding the molecular pathogenesis of LQT1 and provides a novel insight into the adrenergic regulation of this disease.

4 August 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
CDChao Dong
Chao Dong
JLJiawei Li
Jiawei Li
MZMing Zhao
Ming Zhao
LCLin Chen
Lin Chen
XZXiaochen Zhai
Xiaochen Zhai
XXXiaolu Xie
Xiaolu Xie
Panax notoginseng saponins (PNS), bioactive compounds, are commonly used to treat ischemic heart and cerebral diseases in China and other Asian countries. Most previous studies of PNS have focused on the mechanisms underlying their treatment of ischemic cardiovascular diseases but not cerebral ischemic diseases. This study sought to explore the pharmacological mechanisms underlying the effectiveness of PNS in treating cerebral ischemic diseases. Different experimental cerebral ischemia models (including middle cerebral artery occlusion (MCAO) and the blockade of four arteries in rats, collagen‐adrenaline‐induced systemic intravascular thrombosis in mice, thrombosis of carotid artery‐jugular vein blood flow in the bypass of rats, and hypoxia tolerance in mice) were used to investigate the mechanisms underlying the actions of PNS on cerebral ischemia. The results indicated that (1) PNS improved neurological function and reduced the cerebral ischemia infraction area in MCAO rats; (2) PNS improved motor coordination function in rats with complete cerebral ischemia (blockade of four arteries), decreased Ca2+ levels, and ameliorated energy metabolism in the brains of ischemia rats; (3) PNS reduced thrombosis in common carotid artery‐jugular vein blood flow in the bypass of rats; (4) PNS provided significant promise in antistroke hemiplegia and hypoxia tolerance in mice. In conclusion, PNS showed antagonistic effects on ischemic stroke, and pharmacological mechanisms are likely to be associated with the reduction of cerebral pathological damage, thrombolysis, antihypoxia, and improvement in the intracellular Ca2+ overload and cerebral energy metabolism.

16 September 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
CDChao Dong
Chao Dong
JLJiawei Li
Jiawei Li
WDWeiguang Ding
Weiguang Ding
RURika Ueda
Rika Ueda
XXXiaolu Xie
Xiaolu Xie
MHMinoru Horie
Minoru Horie
Kv1.5 channels conduct the ultra-rapid delayed rectifier potassium current (IKur). Pharmacological blockade of human Kv1.5 (hKv1.5) has been regarded as an effective treatment of re-entrant based atrial fibrillation, because Kv1.5 is highly expressed in human cardiac atria but scarcely in ventricles. The Kv1.5 blockade is also expected to be used in cancer therapeutics since Kv1.5 is overexpressed in some types of human tumors. Here, we investigated the blockade of hKv1.5 channels by HMQ1611, a symmetrical biphenyl derivative. hKv1.5 channels were heterologously expressed in Chinese hamster ovary cells. The effects of HMQ1611 on wild-type and 13 hKv1.5 mutant channels were examined using the whole-cell patch-clamp method, and molecular docking simulation was conducted to predict the docking position of HMQ1611 within Kv1.5 channels. We showed that HMQ1611 reversibly inhibited the hKv1.5 current in a concentration-dependent manner (IC50 = 2.07 μM). HMQ1611 blockade of hKv1.5 current developed with time during depolarizing voltage-clamp steps, and this blockade was also voltage-dependent with a steep increase over the voltage range for channel openings. HMQ1611 inhibition was significantly reduced in the T479A, T480A, V505A, I508A, L510A, V512A, and V516A hKv1.5 mutant channels. Molecular docking analysis predicted that V505, V512, and T480 were involved in the blocking action of HMQ1611 on hKv1.5 channels. These results suggest that HMQ1611 inhibits hKv1.5 currents as an open channel blocker. Amino acid residues located at the base of the selectivity filter (T479 and T480) and in the S6 segment (V505, I508, L510, V512, and V516) of hKv1.5 appear to constitute potential binding sites for HMQ1611.

9 September 2026 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
RNRui Niu
Rui Niu
JLJiawei Li
Jiawei Li
HFHuanle Fang
Huanle Fang
WZWei Zhao
Wei Zhao
CDChao Dong
Chao Dong
MHMinoru Horie
Minoru Horie
Background and purpose: Atrial fibrillation (AF) is the most prevalent clinical arrhythmia, yet current antiarrhythmic pharmacotherapies have limited efficacy and pose risks of off-target ventricular block. LY294002 was reported to inhibit the ultrarapid delayed-rectifier potassium current ( I Kur ) carried by Kv1.5 channels, a promising atrium-selective therapeutic target for AF. To determine whether LY294002 exhibits functional selectivity for I Kur , this study comprehensively examined its inhibitory effects on major counter-target cardiac ion currents. Methods: The cDNAs encoding the principal pore-forming subunits of major cardiac channels—mediating I Kr (Kv11.1), I Ks (Kv7.1), I K1 (Kir2.1), I to (Kv4.3), I Na (Nav1.5), and I Ca-L (Cav1.2)—were heterologously expressed in Chinese hamster ovary cells. The inhibitory effects of LY294002 on these channels were assessed using the whole-cell patch-clamp technique. Furthermore, molecular docking analysis was conducted to characterize the structural interactions and binding configurations of LY294002 with Kv1.5. Results: LY294002 inhibited all investigated currents in a concentration-dependent manner, albeit with markedly varying potencies. Based on Hill equation fits, the half-maximal inhibitory concentration (IC 50 ) values for LY294002 on I Ks , I Kr , I to , I K1 , I Na , and I Ca-L were 21.5, 26.3, 55.9, 81.5, 131.6, and 46.5 μM, respectively. Notably, the lowest off-target IC 50 ( I Ks ) was approximately 2.7-fold higher than the previously reported IC 50 for I Kur (7.9 μM). Molecular docking analysis revealed that LY294002 bound within the internal cavity of Kv1.5, with predicted binding affinity of −8.3 kcal I mol −1 . Conclusion: The inhibitory potency of LY294002 against I Kur is substantially higher than its potency against other major cardiac currents, demonstrating its potential to act as a selective I Kur blocker. Structurally, this preferential inhibition is likely mediated by the compound’s favorable occupancy of key gating or pore regions unique to the Kv1.5 channel conformation.

1 December 2019
Verified
Conference Paper
Closed access
DLDan Liu
Dan Liu
XLXiaowan Li
Xiaowan Li
LLLing Liang
Ling Liang
JWJie Wu
Jie Wu
GXGuanghua Xu
Guanghua Xu
SZShiming ZHOU
Shiming ZHOU
The traditional process of equipment state change is described by feature quantities, but the hidden knowledge of equipment contained in feature quantities is less, and the change of single feature is not enough to judge the change of equipment state. Therefore, it is very important to describe the operation status of equipment and visually display it, so as to establish the direct relationship between status and graphics. It is also an important way to improve the usability of equipment condition monitoring technology. Aiming at the above problems, the failure process of mechanical equipment is analyzed firstly, and then the distribution characteristics of plane representation of equipment status data are analyzed. Then, a method of condition monitoring of mechanical equipment based on data boundary shape after planarization is proposed to realize real-time tracking of equipment status. At the same time, a monitoring and alarming method for mechanical equipment based on the data boundary shape after planarization is proposed. Finally, the validity of the method is verified by bearing experimental data.